As shown in Figure 1 and Figures S1b and S2b, sPD-L1 can differentiate between clinically significant and non-significant prostate cancer and is associated with higher tumor stages (p = 0.031) and ISUP grading (p = 0.026) in PCa. This evidence concerns the gene SPDL1 and prostate carcinoma.